News & Press Featured Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire • May 13, 2025 Read More All Press Releases Press Releases Sail Biomedicines Appoints Martin Mackay, Ph.D., to Its Board of Directors October 23, 2025 Sail Biomedicines to Present New Preclinical Data on Malaria eRNA™ Vaccine Candidates at the 2025 Grand Challenges Annual Meeting June 2, 2025 Q&A: Is the key to personalised medicine programmability? Pharmaceutical Manufacturer • May 30, 2025 Designing Our Way Toward Circular RNA Medicines With AI Advancing RNA • May 30, 2025 Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire • May 13, 2025 Rajesh Ramaswamy: Teaching Machines to Generate Tomorrow's Medicines January 8, 2025 Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board Business Wire • April 2, 2024 Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines Business Wire • January 5, 2024 Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board Business Wire • January 4, 2024 Load More Press Releases Sail Biomedicines Appoints Martin Mackay, Ph.D., to Its Board of Directors October 23, 2025